格隆汇10月24日丨健康元(600380.SH)公布，公司第三季度实现营业收入35.79亿元，同比下降2.31%； 归属于上市公司股东的净利润3.06亿元，同比下降8.61%；归属于上市公司股东的扣除非经常性损益的 净利润2.88亿元，同比下降7.43%；基本每股收益0.17元。 ...

人民财讯10月24日电，健康元（600380）10月24日发布2025年三季报，公司第三季度营业收入35.79亿 元，同比下降2.31%；净利润3.06亿元，同比下降8.61%。2025年前三季度营业收入114.78亿元，同比下 降3.54%；净利润10.91亿元，同比下降1.83%；基本每股收益0.6元。 ...

健康元10月24日公告，2025年第三季度实现营业收入35.79亿元，同比下降2.31%；归属于上市公司股东 的净利润3.06亿元，同比下降8.61%；基本每股收益0.17元。 ...

Core Viewpoint - Health元's stock price has shown fluctuations with a year-to-date increase of 11.65%, while recent trading periods indicate a slight decline [1][2]. Company Overview - Health元 Pharmaceutical Group Co., Ltd. is located in Nanshan District, Shenzhen, Guangdong Province, established on December 18, 1992, and listed on June 8, 2001 [1]. - The company operates as a comprehensive pharmaceutical enterprise, primarily engaged in the research, development, and production of traditional Chinese medicine, health products, and Western medicine [1]. Financial Performance - For the first half of 2025, Health元 reported operating revenue of 7.898 billion yuan, a year-on-year decrease of 4.08%, while net profit attributable to shareholders increased by 1.10% to 785 million yuan [2]. - Cumulatively, the company has distributed 3.979 billion yuan in dividends since its A-share listing, with 1.04 billion yuan distributed over the past three years [3]. Shareholder Information - As of June 30, 2025, Health元 had 76,300 shareholders, a decrease of 4.32% from the previous period, with an average of 23,991 circulating shares per shareholder, an increase of 4.52% [2]. - The top circulating shareholder is Hong Kong Central Clearing Limited, holding 68.3785 million shares, an increase of 14.9969 million shares from the previous period [3].

证券日报网讯 10月13日晚间，健康元发布公告称，截至2025年9月30日，本公司及控股子公司无对外担 保逾期的情况。 （文章来源：证券日报） ...

健康元药业集团 担保进展公告 证券代码：600380 证券简称：健康元 公告编号：临 2025-067 健康元药业集团股份有限公司 关于为控股子公司提供担保进展情况的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●担保对象及基本情况 | | 被担保人名称 | 古田福兴医药有限公司 | | | --- | --- | --- | --- | | | 本次担保金额 | 5,750 万元 | | | 担保对象一 | 实际为其提供的担保余额 | 1,280.24 万元 | | | | 是否在前期预计额度内 | √是 □否 | □不适用：_________ | | | 本次担保是否有反担保 | √是 □否 | □不适用：_________ | | | 被担保人名称 | | 焦作丽珠合成制药有限公司 | | | 本次担保金额 | 23,000 万元 | | | 担保对象二 | 实际为其提供的担保余额 | 17,854.99 | 万元 | | | 是否在前期预计额度内 | √是 □否 | □不适用：_________ ...

Core Viewpoint - Health元's stock price has shown a mixed performance in recent months, with a year-to-date increase of 13.73% and a recent decline over the past 20 days of 7.83% [1] Financial Performance - For the first half of 2025, Health元 reported revenue of 7.898 billion yuan, a year-on-year decrease of 4.08%, while net profit attributable to shareholders was 785 million yuan, reflecting a growth of 1.10% [2] - Cumulative cash dividends since the A-share listing amount to 3.979 billion yuan, with 1.04 billion yuan distributed over the past three years [3] Shareholder Structure - As of June 30, 2025, the number of shareholders for Health元 was 76,300, a decrease of 4.32% from the previous period, with an average of 23,991 circulating shares per person, an increase of 4.52% [2] - The second-largest circulating shareholder is Hong Kong Central Clearing Limited, holding 68.3785 million shares, an increase of 14.9969 million shares from the previous period [3] Market Activity - On September 30, Health元's stock price reached 12.59 yuan per share, with a trading volume of 81.6171 million yuan and a turnover rate of 0.36%, resulting in a total market capitalization of 23.033 billion yuan [1] - The net inflow of main funds was 6.3992 million yuan, with large orders accounting for 31.03% of purchases and 23.19% of sales [1]

Core Viewpoint - As of September 22, a total of 121 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stock with the longest consecutive net buying days is Health元, which has seen net buying for 14 consecutive trading days [1] - Other notable stocks with significant net buying days include Shandong Publishing, Aima Technology, Liu Hua Co., New Light Optoelectronics, Guangming Meat, Songlin Technology, Dashengda, and Shengda Biology [1]

Core Viewpoint - As of September 19, a total of 137 stocks in the Shanghai and Shenzhen markets have experienced net buying from major funds for five consecutive days or more, indicating strong investor interest in these stocks [1] Group 1: Stocks with Significant Net Buying - The stock with the longest consecutive net buying days is Tianpu Co., which has seen net buying for 14 consecutive trading days [1] - Other notable stocks with significant net buying days include Jiankangyuan, Shandong Publishing, Aima Technology, Mosi Co., Botuo Biotechnology, Zhuojin Co., Aolaide, and New Light Optoelectronics [1]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大 遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 健康元药业集团股份有限公司（以下简称：公司）于 2025 年 09 月 19 日（星期五）下 午 15:00-17:00 在上海证券交易所上证路演中心（网址：http://roadshow.sseinfo.com/），以 视频与网络文字互动方式召开了 2025 年半年度业绩说明会，针对公司 2025 年半年度的经 营成果及财务指标等具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内就 投资者普遍关注的问题进行现场回复，现就有关情况公告如下： 一、本次说明会召开情况 健康元药业集团 关于2025年半年度业绩说明会召开情况的公告 证券代码：600380 证券简称：健康元 公告编号：临 2025-066 健康元药业集团股份有限公司 关于 2025 年半年度业绩说明会召开情况的公告 2025 年 09 月 19 日（星期五）下午 15:00-17:00，公司在上海证券交易所上证路演中心 召开 2025 年半年度业绩说明会，公司董事长朱保国先生，董事、总裁林楠棋先生，董事、 副总裁 ...